Daily Medtech News with Smarteeva - 24th Sep

Join us in today's episode of Daily MedTech News with Smarteeva, where we delve into the latest advancements and updates in the medical technology industry.

☑️ FDA approves a study of Alpha Tau Medical’s Alpha DaRT for treating recurrent cutaneous squamous cell carcinoma (cSCC), with objective response rate as the primary efficacy measure.

☑️ Synergia Medical implants its first patients with a neurostimulator for epilepsy treatment, using optoelectronic technology that enhances MRI compatibility.

☑️ Proteomics International reports positive results for its PromarkerEso oesophageal cancer test, designed for early detection and treatment of oesophagal adenocarcinoma (EAC).

☑️ WHO updates its cervical cancer guidelines to include Roche’s dual-stain test, which detects two biomarkers indicating potential cancerous transformation.

☑️ Cercle raises $6M to expand its AI-driven health data platform for women, initially focused on fertility, and plans to broaden its application areas.


#InsightswithSmarteeva #Medtech #complaintmanagement #Pharma #Smarteeva #biotech #medtechtrends #medtechindustry #medicaltechnology #technology #health #medicaldevicediagnostics #ai #mdr #recalls #complaints #mir #fda #cvr